You Searched For "bharat biotech covid 19 vacine" and got 19 results
Sort By:
India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates
The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …
Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN
Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…
PTI
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
Germany to recognise Bharat Biotech’s 'Covaxin' from June 1
In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…
DCGI gives nod to Bharat Biotech's Covaxin for 6-12 age group in India
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event w…
Expert committee recommends Bharat Biotech’s Covaxin for kids aged between 2-18 years
According to media reports, the Hyderabad-based Bharat Biotech had successfully completed its Ph…
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
India's Covaxin 77.8% effective for COVID-19, says Lancet Report
A"The efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic…
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait
The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …
Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study
The results of an interim study recently published in The Lancet showed that two doses of Covaxi…
PTI
OPINION: No matter what Bharat Biotech says, Covaxin is just not ready for approvals
Benefits like how effective the vaccine is in preventing disease, and risks such as high morta…
Bharat Biotech's COVID-19 vaccine COVAXIN is well tolerated with no serious adverse events as per phase 1 trial results
A preprint is a version of a scientific manuscript posted on a public server prior to formal pe…
PTI
Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin
Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …
After Serum Institute of India, Bharat Biotech says it will reduce the cost of COVAXIN for state governments
Bharat Biotech, the company behind the COVID-19 vaccine COVAXIN, has slashed the price of its vacci…
Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…
PTI
CAT admit card 2020 to be released today. Here’s how to download
The Indian Institute of Management (IIM), Indore is likely to release the admit card for Common Adm…